Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)

Olga M. García Morales; Maria Ximena Rojas-Reyes; Rodolfo J. Dennis

doi:10.1002/14651858.CD012748

Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)

Olga M. García Morales
, Maria Ximena Rojas-Reyes
, Rodolfo J. Dennis

Producción científica: Contribución a revista › Artículo de Investigación › revisión exhaustiva

3 Citas (Scopus)

Resumen

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy and safety of adding oral theophylline or doxofylline to usual treatment (long-acting beta₂-agonists, antimuscarinics, inhaled corticosteroids) versus providing usual treatment alone for patients with stable COPD.

Idioma original	Inglés estadounidense
Número de artículo	CD012748
Publicación	Cochrane Database of Systematic Reviews
Volumen	2017
N.º	8
DOI	https://doi.org/10.1002/14651858.CD012748
Estado	Publicada - ago. 3 2017
Publicado de forma externa	Sí

Áreas temáticas de ASJC Scopus

Farmacología (médica)

Acceder al documento

10.1002/14651858.CD012748

Otros archivos y enlaces

Citar esto

@article{c84fb690d4c54bc6a89b5f65cfc9984e,

title = "Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy and safety of adding oral theophylline or doxofylline to usual treatment (long-acting beta2-agonists, antimuscarinics, inhaled corticosteroids) versus providing usual treatment alone for patients with stable COPD.",

author = "\{Garc{\'i}a Morales\}, \{Olga M.\} and Rojas-Reyes, \{Maria Ximena\} and Dennis, \{Rodolfo J.\}",

note = "Funding Information: This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Airways. The views and opinions expressed therein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health. Publisher Copyright: {\textcopyright} 2017 The Cochrane Collaboration. Published by John Wiley \& Sons, Ltd.",

year = "2017",

month = aug,

day = "3",

doi = "10.1002/14651858.CD012748",

language = "English (US)",

volume = "2017",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "8",

}

Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD). / García Morales, Olga M.; Rojas-Reyes, Maria Ximena; Dennis, Rodolfo J.
En: Cochrane Database of Systematic Reviews, Vol. 2017, N.º 8, CD012748, 03.08.2017.

Producción científica: Contribución a revista › Artículo de Investigación › revisión exhaustiva

TY - JOUR

T1 - Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)

AU - García Morales, Olga M.

AU - Rojas-Reyes, Maria Ximena

AU - Dennis, Rodolfo J.

N1 - Funding Information: This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Airways. The views and opinions expressed therein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health. Publisher Copyright: © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

PY - 2017/8/3

Y1 - 2017/8/3

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy and safety of adding oral theophylline or doxofylline to usual treatment (long-acting beta2-agonists, antimuscarinics, inhaled corticosteroids) versus providing usual treatment alone for patients with stable COPD.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy and safety of adding oral theophylline or doxofylline to usual treatment (long-acting beta2-agonists, antimuscarinics, inhaled corticosteroids) versus providing usual treatment alone for patients with stable COPD.

UR - https://www.scopus.com/pages/publications/85028375609

UR - https://www.scopus.com/pages/publications/85028375609#tab=citedBy

U2 - 10.1002/14651858.CD012748

DO - 10.1002/14651858.CD012748

M3 - Research Article

AN - SCOPUS:85028375609

SN - 1465-1858

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 8

M1 - CD012748

ER -

Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)

Resumen

Áreas temáticas de ASJC Scopus

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto